Skip to main content
SpringerLink
Log in

Gynäkologika

  • Chapter
Arzneiverordnungs-Report 2010

  • 679 Accesses

Zusammenfassung

In der Indikationsgruppe Gynäkologika stehen Mittel zur Behandlung von klimakterischen Beschwerden und gynäkologischen Infektionen im Vordergrund. Die größte Gruppe bilden die gynäkologischen Sexualhormonpräparate zur topischen Applikation. Systemisch applizierbare Sexualhormonpräparate werden im Kapitel 42 besprochen. Kleinere Indikationsgruppen bilden die Antiinfektiva, Ovulationsauslöser, Uterusmittel und Prolaktinhemmer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Evans BA, Catterall RD (1970): Nifuratel compared with metronidazole in the treatment of trichomonal vaginitis. BMJ 2: 335–336.

    Article  PubMed  CAS  Google Scholar 

  • Gath D, Iles S (1988): Treating the premenstrual syndrome. Brit Med J 297: 237–238.

    Article  PubMed  CAS  Google Scholar 

  • Joesoef MR, Schmid G P, Hillier SL (1999): Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 28 (Suppl 1): S57–S65.

    Article  PubMed  Google Scholar 

  • Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM (2006): A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 13: 737–743.

    Article  PubMed  Google Scholar 

  • McFadyen IJ, Forrest APM, Raab GM, Macintyre CCA (1989): Progesterone cream for cyclic breast pain. Brit Med J 289: 931.

    Article  Google Scholar 

  • Pharmazeutische Zeitung (2008): Rückruf Methergin Dragees alle Chargen. Pharm Ztg 153 (Nr.51/52): Seite 139.

    Google Scholar 

  • Wren BG, Champion SM, Willets K, Manga RZ, Eden JA (2003): Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause 10: 13–18.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut, der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Prof. Dr. med. Ulrich Schwabe

Authors
  1. Prof. Dr. med. Ulrich Schwabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. AOK Schleswig-Holstein, Die Gesundheitskasse, Edisonstraße 70, 24145, Kiel

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schwabe, U. (2010). Gynäkologika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2010. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13380-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13380-0_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13379-4

  • Online ISBN: 978-3-642-13380-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation